Archimed Acquires Standard BioTools Microfluidics Business
Standard BioTools (LAB) has completed the sale of its microfluidics business to private equity firm Archimed. The spinoff, now named Biomark Scientific, operates as an independent entity focusing on genomic workflows.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed